147 related articles for article (PubMed ID: 8390317)
41. [Drug embolization in pancreatic carcinoid tumor with metastases to the liver].
Dolgushin BI; Kuchinskiĭ GA; Shatikhin VA; Kalashnikov PA
Sov Med; 1991; (4):90-1. PubMed ID: 1871648
[No Abstract] [Full Text] [Related]
42. [Arterial lipiodol chemoembolization of a left liver metastasis through the right internal thoracic artery].
Mignon F; Mesurolle B; Qanadli SD; Sissakian JF; Bruckert F; Barré O; Lacombe P
J Radiol; 1999 Aug; 80(8):872-4. PubMed ID: 10470620
[TBL] [Abstract][Full Text] [Related]
43. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
Dominguez S; Denys A; Menu Y; Ruszniewski P
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
[TBL] [Abstract][Full Text] [Related]
44. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
Desai DC; O'Dorisio TM; Schirmer WJ; Jung SS; Khabiri H; Villanueva V; Martin EW
Regul Pept; 2001 Jan; 96(3):113-7. PubMed ID: 11111016
[TBL] [Abstract][Full Text] [Related]
45. Targeting of different ethiodized oil-doxorubicin mixtures to hypovascular hepatic metastases with intraarterial and intraportal injections.
Cay O; Kruskal J; Thomas P; Clouse ME
J Vasc Interv Radiol; 1996; 7(3):409-17. PubMed ID: 8761823
[TBL] [Abstract][Full Text] [Related]
46. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
Schell SR; Camp ER; Caridi JG; Hawkins IF
J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
[TBL] [Abstract][Full Text] [Related]
47. [Chemoperfusion and embolization in the treatment of liver metastases].
Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
[TBL] [Abstract][Full Text] [Related]
48. Embolization and chemoembolization therapy for neuroendocrine tumors.
Venook AP
Curr Opin Oncol; 1999 Jan; 11(1):38-41. PubMed ID: 9914876
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of liver metastasis of endocrine tumors of the pancreas].
Orozco Zepeda H
Rev Gastroenterol Mex; 1997; 62(1):50-6. PubMed ID: 9190654
[TBL] [Abstract][Full Text] [Related]
50. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
51. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
[TBL] [Abstract][Full Text] [Related]
52. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic islet cell tumors metastatic to the liver: treatment by hepatic artery chemo-embolization.
Valette PJ; Souquet JC
Horm Res; 1989; 32(1-3):77-9. PubMed ID: 2559021
[TBL] [Abstract][Full Text] [Related]
54. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases.
Kamat PP; Gupta S; Ensor JE; Murthy R; Ahrar K; Madoff DC; Wallace MJ; Hicks ME
Cardiovasc Intervent Radiol; 2008; 31(2):299-307. PubMed ID: 17922160
[TBL] [Abstract][Full Text] [Related]
55. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin.
Raoul JL; Heresbach D; Bretagne JF; Ferrer DB; Duvauferrier R; Bourguet P; Messner M; Gosselin M
Cancer; 1992 Aug; 70(3):585-90. PubMed ID: 1320447
[TBL] [Abstract][Full Text] [Related]
56. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
[TBL] [Abstract][Full Text] [Related]
57. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization.
Stuart K; Stokes K; Jenkins R; Trey C; Clouse M
Cancer; 1993 Dec; 72(11):3202-9. PubMed ID: 7694787
[TBL] [Abstract][Full Text] [Related]
58. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
O'Toole D; Ruszniewski P
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
[TBL] [Abstract][Full Text] [Related]
59. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.
Chung JW; Park JH; Han JK; Choi BI; Han MC; Lee HS; Kim CY
Radiology; 1996 Jan; 198(1):33-40. PubMed ID: 8539401
[TBL] [Abstract][Full Text] [Related]
60. Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors.
Gaba RC; Baumgarten S; Omene BO; van Breemen RB; Garcia KD; Larson AC; Omary RA
J Vasc Interv Radiol; 2012 Feb; 23(2):265-73. PubMed ID: 22178040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
